Drawing for ONCOSIGNAL

USPTO serial 97743114

ONCOSIGNAL

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
EVANKO, PATRICIA MALESARDI
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ONCOSIGNAL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Abigail D. LeCroy

Abigail D. LeCroy MILLER & MARTIN PLLC832 GEORGIA AVENUESUITE 1200CHATTANOOGA, TN 37402

Goods and services

ClassDescriptionStatusFirst use
001Chemical products for scientific purposes; biological preparations for use in science; diagnostic preparations for clinical or medical laboratory purposes; diagnostic preparations for research laboratory use; reagents for scientific or research purposes, including medical researchACTIVE—
009Scientific, research and teaching apparatus, instruments and simulators, namely, centrifuges used as laboratory apparatus, laboratory thermocyclers for real time PCR detection, PCR plate foils, RT-qPCR testing plates, PCR test plates, medical diagnostic simulators for use as teaching aids for real time or quantitative PCR and analysis, and medical laboratory research instruments for detecting DNA; laboratory test equipment, namely, PCR plate foils, RT-qPCR testing plates, PCR test plates for use in diagnostic testing, not for medical purposes; analyzers for use in research laboratories for measuring, testing and analyzing bodily materials, namely, blood and other bodily fluids containing DNA; electrical apparatus for the genetic modification of cells for research purposes; quantitative and real time polymerase chain reaction (PCR) instruments for scientific use; data processing equipment; recorded or downloadable software, software platforms, software packages and software applications for collecting and analyzing data, in the field of medical and diagnostic testing; downloadable electronic publications, namely, books, periodicals, magazines, newspapers, pamphlets, brochures, publications, educational and teaching materials in the field of medical and diagnostic testing; media content, namely, downloadable educational multimedia files, featuring medical and diagnostic testing; downloadable podcasts in the field of medical and diagnostic testing; parts of the aforesaid goodsACTIVE—
042Scientific and technological services, namely, analysis and testing in the field of DNA, RNA, genetics, cell biology and PCR ; quality control for others and authentication services in the field of DNA, RNA and PCR testing and measurement and associated data validation; medical and pharmaceutical research services; design and development of medical testing and analysis methods; medical and genetic research and development of drugs and treatment methods for diseases; design and development of diagnostic equipment, instruments and test procedures for medical and pharmaceutical purposes; genetic data mining; designing, developing, testing, programming, installing, updating, upgrading, implementing, maintaining and providing temporary use of online non-downloadable software and computer programs for accessing databases, portals and platforms; information technology services for the pharmaceutical and healthcare industry, namely, data security and hosting services and analysis of genetic and RNA sequencing data files and data validation; development of computer programs for use in the field of medicine and health care; technical advice relating to the design of computer hardware and software relating to the aforesaid analysis of genetic and RNA sequencing data files and data validation services, providing scientific research information relating to medical diagnostic and testing via electronic networks such as the InternetACTIVE—
044Medical and healthcare services; medical and healthcare testing services relating to the diagnosis and treatment of disease; conducting medical examinations and tests for diagnostic or treatment purposes; medical and health services in the field of DNA, RNA, genetics and genetic testing; medical and health advice, consultancy and information relating to the aforesaid services via electronic networks such as the InternetACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
May 18, 2026MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 18, 2026ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 14, 2025NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 19, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 19, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 13, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 11, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 10, 2025XAECEXAMINER'S AMENDMENT ENTERED—
Jul 10, 2025GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jul 10, 2025GNEAEXAMINERS AMENDMENT E-MAILED—
Jul 10, 2025CNEAEXAMINERS AMENDMENT -WRITTEN—
Jul 10, 2025ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Jul 1, 2025PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Jun 6, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 5, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 5, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 5, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 19, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 19, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 19, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 27, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 27, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 27, 2024ALIEASSIGNED TO LIE—
Dec 30, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 30, 2023NREVNOTICE OF REVIVAL - E-MAILED—
Dec 30, 2023NREVNOTICE OF REVIVAL - E-MAILED—
Dec 30, 2023PETGPETITION TO REVIVE-GRANTED—
Dec 30, 2023PROATEAS PETITION TO REVIVE RECEIVED—
Sep 29, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 29, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 29, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 28, 2023DOCKASSIGNED TO EXAMINER—
Jan 29, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 9, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance